ME NOPA U SE SOC I E TY MSC P/NC MP PRA C TI C E
EXAMINATION
NAMS Menopause
Certification Exam
100 board-style questions and answers with detailed,
evidence-based rationales - aligned with current
Menopause Society guidance, STRAW+10 staging, WHI
evidence, and the 2026-2027 examination blueprint.
100 Questions and Answers (Graded A+)
Six Sections - Answer Key with NAMS-Specific Rationales
2 0 2 0 2 7 E D I TI O N | U P D ATE D C L I N I C A L G U I D A N C E
,NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
NAMS Menopause Certification Exam
100 Questions and Answers (Graded A+) | 2026/2027 Edition - Aligned with The Menopause Society
(NAMS) MSCP/NCMP Examination Blueprint and current 2026-2027 clinical guidance
Examination Overview
Total Questions 100 multiple-choice questions (A-D), one correct answer each
Section Structure 6 sections spanning reproductive physiology through integrated clinical cases
Cognitive Levels 25% recall | 50% application | 25% analysis
Question Style 75% scenario-based clinical vignettes | 25% direct recall and definition identification
Correct answer marked [CORRECT] with Correct Answer line and detailed
Answer Format
NAMS-specific rationale for every question
Menopause Society position statements, STRAW+10 staging, WHI evidence, and
Alignment
2026/2027 updates including neurokinin receptor antagonist therapy
Table of Contents
Section 1: Reproductive Physiology and Menopause Staging (Q1-Q18) . . . . . . . . . . . . . . . . . . 2
Section 2: Symptom Management (Q19-Q35) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Section 3: Health Disorders and Clinical Assessment (Q36-Q52) . . . . . . . . . . . . . . . . . . . . . 19
Section 4: Treatment - Hormonal and Non-Hormonal Therapies (Q53-Q70) . . . . . . . . . . . . . . . 27
Section 5: Preventive Care, Counseling, and Special Populations (Q71-Q85) . . . . . . . . . . . . . . . 36
Section 6: Comprehensive Cases and Clinical Application (Q86-Q100) . . . . . . . . . . . . . . . . . . 44
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 1
,NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
Section 1: Reproductive Physiology and Menopause Staging
(Q1-Q18)
Domains: STRAW+10 staging, ovarian aging, hormonal changes, menopause definitions, and POI | Questions 1-18
Q1: Which statement most accurately defines natural menopause according to the STRAW+10 staging
system and The Menopause Society?
A. A clinical retrospective stage defined after 12 consecutive months of amenorrhea without
other pathological or physiological cause [CORRECT]
B. The last menstrual period, regardless of age, confirmed by an elevated random FSH level
C. The permanent cessation of menses confirmed after 6 consecutive months of amenorrhea in a
woman over 45
D. The onset of vasomotor symptoms combined with irregular cycles in a woman in her late 40s
Correct Answer: A
Rationale: Menopause is defined retrospectively: it is diagnosed only after 12 consecutive months of
amenorrhea without any other pathological or physiological explanation, and the final menstrual period (FMP)
is dated back 1 year. Six months of amenorrhea (option C) is insufficient and will misdiagnose women with
prolonged perimenopausal intervals. A random FSH (option B) is unreliable because levels fluctuate widely
during the transition, and vasomotor symptoms with irregular cycles (option D) describe the perimenopausal
transition, not established menopause.
Q2: A 51-year-old woman reports that her menses, previously regular every 28 days, have been 35 to 42
days apart for the past 7 months, and she had hot flashes twice weekly. How should her reproductive
stage be classified using STRAW+10?
A. Postmenopause, because her age is within the expected range for the final menstrual period
B. Middle or late reproductive stage, because cycles are still occurring regularly enough to exclude the
transition
C. Late menopausal transition, because vasomotor symptoms confirm she is within 1 year of the final
menstrual period
D. Early menopausal transition, because cycle length has become persistently variable by more
than 7 days from her baseline [CORRECT]
Correct Answer: D
Rationale: STRAW+10 defines the early menopausal transition (stage -2) by a persistent difference of 7 days
or more in the length of consecutive cycles, which this patient clearly meets. She is not postmenopausal
(option A) because 12 months of amenorrhea have not elapsed, and her cycles are too variable for a
reproductive-stage label (option B). Vasomotor symptoms are nonspecific and are not a staging criterion; the
late transition (option C) is defined by intervals of amenorrhea of 60 days or more, which she has not had.
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 2
, NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
Q3: In the STRAW+10 staging system, which criterion defines entry into the late menopausal transition
(stage -1)?
A. An AMH level below 0.7 ng/mL on two measurements
B. A persistent change of 7 or more days in cycle length compared with baseline
C. An interval of amenorrhea lasting 60 days or more [CORRECT]
D. An FSH level persistently above 40 IU/L on day-2 or day-3 testing
Correct Answer: C
Rationale: The late menopausal transition is defined clinically by at least one skipped cycle or intervals of
amenorrhea of 60 days or longer, reflecting increasingly anovulatory cycles. The 7-day variability criterion
(option B) defines the early transition. AMH (option A) is not used in STRAW+10 staging because it is a
supportive, not defining, marker with assay variability, and FSH above 40 IU/L (option D) is neither required
nor a staging threshold because single FSH values fluctuate excessively during the transition.
Q4: A 54-year-old woman whose last menstrual period was 14 months ago asks when she officially
reached menopause and how she will be staged going forward. Her hot flashes began 3 years ago.
According to STRAW+10, which response is correct?
A. She reached menopause 3 years ago when vasomotor symptoms began, so she is in early
postmenopause
B. She remains in the late menopausal transition until 24 months of amenorrhea have passed
C. She cannot be labeled postmenopausal until FSH exceeds 40 IU/L on two separate day-3 draws
D. Her final menstrual period was 14 months ago; menopause is confirmed now, and she will be
in early postmenopause (stage +1) until approximately 5 to 8 years after the FMP
[CORRECT]
Correct Answer: D
Rationale: Menopause is dated to the final menstrual period and confirmed retrospectively after 12 months of
amenorrhea; with 14 months elapsed, her FMP was 14 months ago and she is now confirmed postmenopausal.
STRAW+10 divides postmenopause into early (stage +1, roughly the first 5 to 8 years after the FMP) and late
(stage +2) phases, so she is in early postmenopause. Symptom onset (option A) is not a staging anchor, FSH
thresholds (option C) are not required for diagnosis at her age, and only 12 months - not 24 - of amenorrhea
are needed (option B).
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 3
EXAMINATION
NAMS Menopause
Certification Exam
100 board-style questions and answers with detailed,
evidence-based rationales - aligned with current
Menopause Society guidance, STRAW+10 staging, WHI
evidence, and the 2026-2027 examination blueprint.
100 Questions and Answers (Graded A+)
Six Sections - Answer Key with NAMS-Specific Rationales
2 0 2 0 2 7 E D I TI O N | U P D ATE D C L I N I C A L G U I D A N C E
,NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
NAMS Menopause Certification Exam
100 Questions and Answers (Graded A+) | 2026/2027 Edition - Aligned with The Menopause Society
(NAMS) MSCP/NCMP Examination Blueprint and current 2026-2027 clinical guidance
Examination Overview
Total Questions 100 multiple-choice questions (A-D), one correct answer each
Section Structure 6 sections spanning reproductive physiology through integrated clinical cases
Cognitive Levels 25% recall | 50% application | 25% analysis
Question Style 75% scenario-based clinical vignettes | 25% direct recall and definition identification
Correct answer marked [CORRECT] with Correct Answer line and detailed
Answer Format
NAMS-specific rationale for every question
Menopause Society position statements, STRAW+10 staging, WHI evidence, and
Alignment
2026/2027 updates including neurokinin receptor antagonist therapy
Table of Contents
Section 1: Reproductive Physiology and Menopause Staging (Q1-Q18) . . . . . . . . . . . . . . . . . . 2
Section 2: Symptom Management (Q19-Q35) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Section 3: Health Disorders and Clinical Assessment (Q36-Q52) . . . . . . . . . . . . . . . . . . . . . 19
Section 4: Treatment - Hormonal and Non-Hormonal Therapies (Q53-Q70) . . . . . . . . . . . . . . . 27
Section 5: Preventive Care, Counseling, and Special Populations (Q71-Q85) . . . . . . . . . . . . . . . 36
Section 6: Comprehensive Cases and Clinical Application (Q86-Q100) . . . . . . . . . . . . . . . . . . 44
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 1
,NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
Section 1: Reproductive Physiology and Menopause Staging
(Q1-Q18)
Domains: STRAW+10 staging, ovarian aging, hormonal changes, menopause definitions, and POI | Questions 1-18
Q1: Which statement most accurately defines natural menopause according to the STRAW+10 staging
system and The Menopause Society?
A. A clinical retrospective stage defined after 12 consecutive months of amenorrhea without
other pathological or physiological cause [CORRECT]
B. The last menstrual period, regardless of age, confirmed by an elevated random FSH level
C. The permanent cessation of menses confirmed after 6 consecutive months of amenorrhea in a
woman over 45
D. The onset of vasomotor symptoms combined with irregular cycles in a woman in her late 40s
Correct Answer: A
Rationale: Menopause is defined retrospectively: it is diagnosed only after 12 consecutive months of
amenorrhea without any other pathological or physiological explanation, and the final menstrual period (FMP)
is dated back 1 year. Six months of amenorrhea (option C) is insufficient and will misdiagnose women with
prolonged perimenopausal intervals. A random FSH (option B) is unreliable because levels fluctuate widely
during the transition, and vasomotor symptoms with irregular cycles (option D) describe the perimenopausal
transition, not established menopause.
Q2: A 51-year-old woman reports that her menses, previously regular every 28 days, have been 35 to 42
days apart for the past 7 months, and she had hot flashes twice weekly. How should her reproductive
stage be classified using STRAW+10?
A. Postmenopause, because her age is within the expected range for the final menstrual period
B. Middle or late reproductive stage, because cycles are still occurring regularly enough to exclude the
transition
C. Late menopausal transition, because vasomotor symptoms confirm she is within 1 year of the final
menstrual period
D. Early menopausal transition, because cycle length has become persistently variable by more
than 7 days from her baseline [CORRECT]
Correct Answer: D
Rationale: STRAW+10 defines the early menopausal transition (stage -2) by a persistent difference of 7 days
or more in the length of consecutive cycles, which this patient clearly meets. She is not postmenopausal
(option A) because 12 months of amenorrhea have not elapsed, and her cycles are too variable for a
reproductive-stage label (option B). Vasomotor symptoms are nonspecific and are not a staging criterion; the
late transition (option C) is defined by intervals of amenorrhea of 60 days or more, which she has not had.
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 2
, NAMS Menopause Certification Exam - 100 Questions and Answers (Graded A+) | 2026/2027
Q3: In the STRAW+10 staging system, which criterion defines entry into the late menopausal transition
(stage -1)?
A. An AMH level below 0.7 ng/mL on two measurements
B. A persistent change of 7 or more days in cycle length compared with baseline
C. An interval of amenorrhea lasting 60 days or more [CORRECT]
D. An FSH level persistently above 40 IU/L on day-2 or day-3 testing
Correct Answer: C
Rationale: The late menopausal transition is defined clinically by at least one skipped cycle or intervals of
amenorrhea of 60 days or longer, reflecting increasingly anovulatory cycles. The 7-day variability criterion
(option B) defines the early transition. AMH (option A) is not used in STRAW+10 staging because it is a
supportive, not defining, marker with assay variability, and FSH above 40 IU/L (option D) is neither required
nor a staging threshold because single FSH values fluctuate excessively during the transition.
Q4: A 54-year-old woman whose last menstrual period was 14 months ago asks when she officially
reached menopause and how she will be staged going forward. Her hot flashes began 3 years ago.
According to STRAW+10, which response is correct?
A. She reached menopause 3 years ago when vasomotor symptoms began, so she is in early
postmenopause
B. She remains in the late menopausal transition until 24 months of amenorrhea have passed
C. She cannot be labeled postmenopausal until FSH exceeds 40 IU/L on two separate day-3 draws
D. Her final menstrual period was 14 months ago; menopause is confirmed now, and she will be
in early postmenopause (stage +1) until approximately 5 to 8 years after the FMP
[CORRECT]
Correct Answer: D
Rationale: Menopause is dated to the final menstrual period and confirmed retrospectively after 12 months of
amenorrhea; with 14 months elapsed, her FMP was 14 months ago and she is now confirmed postmenopausal.
STRAW+10 divides postmenopause into early (stage +1, roughly the first 5 to 8 years after the FMP) and late
(stage +2) phases, so she is in early postmenopause. Symptom onset (option A) is not a staging anchor, FSH
thresholds (option C) are not required for diagnosis at her age, and only 12 months - not 24 - of amenorrhea
are needed (option B).
Menopause Society MSCP/NCMP Examination Practice Test - Answer Key with Rationales 3
